The prognostic value of the CD11b-CD169-based MRS was not only shown in predicting the postoperative recurrence of iCCA, but was also applied into a prognostic nomogram that may help the personalized prediction and clinical decision. This evidence concerns the gene ITGAM and infantile convulsions and choreoathetosis.